- Home
- HCM vs RCAT Comparison
HCM vs RCAT Comparison
Compare HCM & RCAT Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
Current Price
Company Overview
Basic Information| Metric | HCM | RCAT |
|---|---|---|
| Founded | 2000 | 2002 |
| Country | Hong Kong | United States |
| Employees | 1796 | N/A |
| Industry | Biotechnology: Pharmaceutical Preparations | Wholesale Distributors |
| Sector | Health Care | Industrials |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 2.3B | 1.9B |
| IPO Year | N/A | 2017 |
Fundamental Metrics
Financial Performance| Metric | HCM | RCAT |
|---|---|---|
| Price | $13.18 | $11.14 |
| Analyst Decision | Sell | Strong Buy |
| Analyst Count | 1 | 2 |
| Target Price | $13.75 | ★ $20.00 |
| AVG Volume (30 Days) | 28.0K | ★ 9.2M |
| Earning Date | 03-05-2026 | 05-07-2026 |
| Dividend Yield | N/A | N/A |
| EPS Growth | ★ N/A | N/A |
| EPS | ★ N/A | N/A |
| Revenue | N/A | ★ $17,836,382.00 |
| Revenue This Year | $20.60 | $271.60 |
| Revenue Next Year | $15.62 | $41.21 |
| P/E Ratio | $5.49 | ★ N/A |
| Revenue Growth | N/A | ★ 79.95 |
| 52 Week Low | $12.82 | $5.12 |
| 52 Week High | $19.50 | $18.78 |
Technical Indicators
Market Signals| Indicator | HCM | RCAT |
|---|---|---|
| Relative Strength Index (RSI) | 32.49 | 41.41 |
| Support Level | $13.08 | $11.01 |
| Resistance Level | $15.59 | $13.69 |
| Average True Range (ATR) | 0.44 | 0.86 |
| MACD | -0.21 | -0.11 |
| Stochastic Oscillator | 13.68 | 15.69 |
Price Performance
Historical ComparisonAbout HCM HUTCHMED (China) Limited
HUTCHMED (China) Ltd is a biopharmaceutical company engaged in the discovery, development, and commercialization of targeted therapies and immunotherapies for the treatment of cancer and immunological diseases. The company has a portfolio of several cancer drug candidates currently in clinical studies world-wide and an extensive commercial infrastructure in its home market, China. The company operates in two reportable segments: Oncology/Immunology and Other Ventures.
About RCAT Red Cat Holdings Inc.
Red Cat Holdings Inc is a drone technology company integrating robotic hardware and software for military, government, and commercial operations. Red Cat's suite of solutions includes the Arachnid family of ISR and precision strike drones, which includes the Black Widow, a small unmanned ISR system; and WEB (Warfighter Electronic Bridge) GCS, designed to command and control an entire drone family of systems for military operations. Its other offerings include Edge 130 Blue drone systems, Trichon, a fixed-wing VTOL for extended endurance and range, and FANG FPV drones optimized for military operations with precision strike capabilities.